The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
about
The great escape: viral strategies to counter BST-2/tetherinBroad-spectrum inhibition of retroviral and filoviral particle release by tetherinHIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsAntiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteractionThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsThe role of BST-2/Tetherin in host protection and disease manifestationVpu Protein: The Viroporin Encoded by HIV-1Conformational changes induced by a single amino acid substitution in thetrans-membrane domain of Vpu: Implications for HIV-1 susceptibility to channel blocking drugsImmunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membraneCounteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu geneVpu and BST2: Still Not There Yet?Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulationThe antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti).HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.Using death to one's advantage: HIV modulation of apoptosis.Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle productionDegranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?Nef proteins from simian immunodeficiency viruses are tetherin antagonists.Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartmentsSome human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral AntagonismA noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytesExpression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cellsEnhanced antagonism of BST-2 by a neurovirulent SIV envelopeIdentification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.HIV accessory proteins versus host restriction factors.Human cellular restriction factors that target HIV-1 replication.HIV-1 Vpu - an ion channel in search of a job.Simian immunodeficiency virus SIVagm from African green monkeys does not antagonize endogenous levels of African green monkey tetherin/BST-2.Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression.Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.
P2860
Q21090506-87120CF5-FDD3-41C6-BFD1-6E6A9267764DQ24318564-52CF41EC-28F7-4EDA-B001-36CDB317BF61Q24619066-FE4E426F-5A2B-4ACD-8A3F-85CE1EA54A8DQ24635271-716F2040-685A-41CF-B7F5-E182D45C6DF0Q24670601-6BCF2D7E-F8AA-462B-B2D3-4162726805CCQ26752737-7B4AC4DD-CDD9-472A-9D77-70578E7F6341Q26801489-BD56AC6C-330B-4DA4-8CE8-DA90F61F06F8Q27647751-A8C45058-7222-4C31-A65E-E42E536C5B9AQ28472771-0B8B19D8-432D-4AC4-ACE1-F890633BAF68Q28730542-58BDDE71-F25F-4E12-A989-D675F1A7F426Q28730708-A9ED5A56-92DE-4056-BD6C-03D7DE5F11C0Q30382590-0C6B69EC-E5E4-4F28-A2E3-48DEE08B5359Q33450556-CEF7065F-A28F-4515-8788-A7353CB7D1AFQ33639849-EA13D647-B900-4119-B795-6DE3B4B46B8CQ33640055-EB3FDA3B-DB4E-458F-A521-7C6F14C18A82Q33737672-E0A02C71-4A5E-4D4D-B491-EDC8882D9502Q33800544-E585E7B9-3AA0-4BCB-9B8C-FDD7A56BB047Q33802684-0F9E8018-8EF1-427A-87CE-D3F1280DFEA5Q33843237-97071A6C-64D9-4C04-AC38-263778435CE0Q33966596-9C0AFE8A-63DA-4166-9667-5324170BDA7EQ34173884-35CCE3D3-9E58-4036-91E0-8F52E28C8EC6Q34391721-0EB2991D-C2AC-40D3-9395-6F69C3E250CDQ34423336-ECECAC60-A2CE-4EA7-9DDD-AA19148864C0Q34492477-F784A0AD-A6C5-4230-B5D0-43DA6D372A6EQ34658653-9A84A779-F1FA-41AE-A982-F63E88F24F5FQ35215406-77237AB8-B228-4B6A-960B-98127156F1BEQ35383070-4F429C1A-E512-4AD1-9D7F-23DC81D91351Q35531194-1BD83F43-34AD-41EE-8739-8C5E95DA9B2BQ35607295-55FD7EA6-8814-4FB8-B0F1-90073E659D94Q35826758-9C7AEF79-8913-4FE9-93A1-A6BC177E1B49Q36639042-F7FDAD55-F8D1-4DAC-AEC9-92B866794A71Q36911742-299BE765-F59B-4C31-9D1C-A731DF0AFBBFQ36951741-AE4F1C30-9CCD-4C8A-A573-3C390004A574Q37120188-064514B6-440B-4B17-AF69-4C302E57F0B9Q37375080-F69BA2CD-3AA4-44F4-91E8-55DE6F3C8605Q37382519-FAAE4F8A-7049-4475-8067-726806BD3B38Q37384691-D2446CA4-5631-4B1E-BBD3-BBDB23FC4582Q37410620-79E212ED-ED2F-4CA2-95AD-BFC758597329Q37431534-6017ABC2-CFA1-4DE3-B83A-775BE3DCEDA4Q37448301-7896104E-434E-4B02-8C65-F07ED3D79EB2
P2860
The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The human immunodeficiency vir ...... of heterologous retroviruses.
@ast
The human immunodeficiency vir ...... of heterologous retroviruses.
@en
type
label
The human immunodeficiency vir ...... of heterologous retroviruses.
@ast
The human immunodeficiency vir ...... of heterologous retroviruses.
@en
prefLabel
The human immunodeficiency vir ...... of heterologous retroviruses.
@ast
The human immunodeficiency vir ...... of heterologous retroviruses.
@en
P2860
P1433
P1476
The human immunodeficiency vir ...... e of heterologous retroviruses
@en
P2093
P2860
P304
P407
P50
P577
1996-12-01T00:00:00Z